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Introduction {#sec1}
============

Evidence is emerging that neurological symptoms in prion diseases precede neuronal loss and are due to an adverse effect of misfolded prion protein (PrP) on synaptic function. Therapeutic intervention, therefore, requires identification of the mechanisms by which abnormal PrP disrupts normal neuronal activity. Here, we describe the mechanism underlying the neurotransmission defect associated with early motor impairment in transgenic (Tg) mouse models of genetic prion disease. This has brought to light an unexpected effect of misfolded PrP on the intracellular trafficking of voltage-gated calcium channels (VGCCs).

Prion diseases, including Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal insomnia, are rare neurodegenerative disorders characterized pathologically by neuronal loss, astrocytosis, and deposition of insoluble PrP aggregates throughout the brain ([@bib50]). They usually involve loss of motor coordination and other motor abnormalities, dementia and neurophysiological deficits, and are invariably fatal ([@bib37]). Approximately 15% of human prion diseases are inherited in an autosomal-dominant fashion and are linked to point mutations or insertions in the gene encoding PrP on chromosome 20 ([@bib45]). The neurotoxic pathways activated by mutant PrP are not clear, but misfolding and oligomerization of the mutant protein are thought to trigger the pathogenic process ([@bib7]).

Tg mice expressing a mouse PrP homolog of a 72 amino acid insertion (PG14), which in humans is associated with progressive dementia and ataxia, synthesize a misfolded form of mutant PrP in their brains that is aggregated into small oligomers ([@bib8; @bib10]). As these mice age, they develop a fatal neurological disorder characterized clinically by ataxia, and neuropathologically by cerebellar atrophy due to loss of synaptic endings in the molecular layer and massive apoptosis of granule neurons ([@bib9]). Deletion of the proapoptotic gene *Bax* in Tg(PG14) mice rescues cerebellar granule cells but does not prevent synaptic loss in the molecular layer and development of clinical symptoms ([@bib11]); thus, mutant PrP causes neurological disease by disrupting the normal neuronal connectivity or function in the cerebellum. PG14 PrP molecules misfold soon after synthesis in the endoplasmic reticulum (ER) ([@bib16]), and their exit from the ER is impaired ([@bib21]). However, ER stress-related pathways are not activated ([@bib52]), suggesting that intracellular retention of PG14 PrP may trigger some other pathogenic mechanisms.

Here, we report that motor behavioral deficits in Tg(PG14) mice emerge before neurodegeneration and are associated with defective depolarization-induced glutamate exocytosis from cerebellar granule neurons (CGNs). Altered calcium influx due to inefficient membrane delivery of VGCCs accounts for the exocytosis defect and is causally linked to intracellular retention of mutant PrP. Confirming this, alterations in VGCC transport and glutamate exocytosis are also found in cells and in Tg mice expressing a mouse PrP homolog of the D178N mutation linked to inherited CJD. These results provide new insights into the mechanism of neuronal dysfunction in genetic prion diseases.

Results {#sec2}
=======

Tg(PG14) Mice Develop Early Impairment in Motor and Balance Coordination Associated with Low Glutamate Release in the Cerebellum {#sec2.1}
--------------------------------------------------------------------------------------------------------------------------------

The Tg(PG14) mice used in this study express mutant PrP at a level similar to endogenous PrP in wild-type mice; they develop ataxia, kyphosis, and foot clasp reflex at ∼240 days of age and die prematurely at ∼450 days ([@bib8; @bib9]).

To find out the earliest appearance of motor dysfunction, Tg(PG14) mice were tested on the accelerating Rotarod. This motor behavioral task requires the mice to walk on an accelerating rotating rod with latency to fall as readout, and is a sensitive indicator of cerebellar abnormalities ([@bib32; @bib66]). Tg(PG14) mice performed well between 19 and 25 days of age (see [Figure S1](#app2){ref-type="sec"}A available online), confirming normal postnatal development of the cerebellum (which is completed in the third week of life) and motor learning ([@bib9]). From 45 days on, however, the mice showed a significantly shorter latency to fall than non-Tg littermates and Tg(WT) mice expressing wild-type PrP ([@bib8]); their performance worsened with aging until they became virtually unable to perform the task ([Figure 1](#fig1){ref-type="fig"}A).

We used MRI to see whether the emergence of the motor deficit was associated with cerebellar degeneration. Tg(PG14) mice were examined at ∼50 and ∼250 days of age, with age-matched non-Tg and Tg(WT) controls. At 50 days the cerebellar volume of Tg(PG14) mice was comparable to controls ([Figures 1](#fig1){ref-type="fig"}B and 1C). In older Tg(PG14) mice there was a significant atrophy of the cerebellum ([Figures 1](#fig1){ref-type="fig"}B and 1C), consistent with previous histological analysis showing age-dependent cerebellar degeneration ([@bib9]).

To investigate changes in cerebellar synaptic structures, we immunostained the brains of young and old animals with an antibody against the vesicular glutamate transporter VGLUT1, which specifically labels glutamatergic projections of CGNs in the molecular layer of the cerebellum ([@bib27]). There was no difference in VGLUT1 immunostaining between young non-Tg and Tg(PG14) mice, whereas a significant decrease was seen in older Tg(PG14) mice ([Figures S1](#app2){ref-type="sec"}B--S1D). There were also no differences between ∼50-day-old non-Tg and Tg(PG14) mice in the levels of the synaptic vesicle-associated proteins synaptophysin and synapsin I, the SNARE protein SNAP-25, the synaptic vesicle fusion protein synaptotagmin I, and the secretory vesicle chaperone CSPα (data not shown), confirming that there was no synaptic degeneration at this stage.

To identify abnormalities in cerebellar neurotransmission, we did functional studies in purified synaptosomal fractions. Synaptosomes were isolated from the cerebellum and cerebral cortex of Tg(WT) and Tg(PG14) mice, and characterized biochemically ([Figures S2](#app2){ref-type="sec"}A--S2C). Synaptosomal PG14 PrP was detergent insoluble (seen in the pellet fraction after ultracentrifugation, [Figures S2](#app2){ref-type="sec"}D and S2E), and was immunoprecipitated by monoclonal antibody 15B3 ([Figure S2](#app2){ref-type="sec"}F), which selectively recognizes aggregated forms of misfolded PrP ([@bib3]). We analyzed synaptosomal uptake and release of glutamate and GABA, which are the main excitatory and inhibitory neurotransmitters in the cerebellum. There were no differences in \[^3^H\]glutamate and \[^3^H\]GABA uptake or spontaneous or depolarization-induced \[^3^H\]GABA release between Tg(WT) and Tg(PG14) mice up to 300 days old (data not shown). To assess release from glutamatergic terminals, we used \[^3^H\]D-aspartate, a nonmetabolizable analog of glutamate ([@bib60]). We found a significant reduction in depolarization-induced release in the cerebellar synaptosomes from Tg(PG14) mice compared to Tg(WT), PrP knockout (*Prnp*^0/0^), and C57BL/6 (*Prnp*^+/+^) mice ([Figure 2](#fig2){ref-type="fig"}A). Release was already significantly reduced in cerebellar synaptosomes from 30- to 70-day-old animals, correlating with the onset of the motor deficit, and was almost completely impaired by the time mice had advanced clinical disease ([Figure 2](#fig2){ref-type="fig"}B). In the cerebral cortex a significant decrease in \[^3^H\]D-aspartate release was found only in mice between 134 and 162 days old ([Figure 2](#fig2){ref-type="fig"}C).

Defective Glutamate Release Is Due to Impaired VGCC Function in CGNs {#sec2.2}
--------------------------------------------------------------------

Depolarization induces neurotransmitter release from synaptic terminals by triggering calcium influx through the VGCC, followed by exocytosis of synaptic vesicles ([@bib61]). To determine whether the release defect in the cerebellum of Tg(PG14) mice was due to defective exocytosis, we used ionomycin, a calcium ionophore that allows calcium influx independently of VGCCs. Ionomycin evoked efficient calcium-dependent \[^3^H\]D-aspartate release from PG14 cerebellar synaptosomes unresponsive to depolarization ([Figures S3](#app2){ref-type="sec"}A--S3C), indicating that the glutamate exocytotic machinery functioned normally in the mutant mice, and pointing to a VGCC defect.

Next, we measured depolarization- and ionomycin-induced calcium rise in synaptosomes preloaded with the calcium-sensitive dye fura-2 AM. Depolarization-induced calcium influx was significantly lower in PG14 cerebellar synaptosomes than in controls ([Figures 2](#fig2){ref-type="fig"}D and [S3](#app2){ref-type="sec"}D), whereas there was no difference after stimulus with ionomycin ([Figures S3](#app2){ref-type="sec"}E and S3F). No difference in depolarization-induced calcium rise was seen in synaptosomes from the cerebral cortex (data not shown).

Because CGNs are the main glutamatergic cell population in the cerebellum, and specifically targeted in Tg(PG14) mice, we reasoned that the defect could pertain to this cell type. We, therefore, measured depolarization-evoked \[^3^H\]D-aspartate release in primary CGN cultures from the Tg(PG14) mice. Release was significantly lower in PG14 than in wild-type cells ([Figure 3](#fig3){ref-type="fig"}A). Single-cell calcium imaging found impaired calcium influx in response to depolarization ([Figures 3](#fig3){ref-type="fig"}B and 3C), and whole-cell patch-clamp recordings showed reduced calcium current densities in PG14 CGNs ([Figures 3](#fig3){ref-type="fig"}D and 3E). There were no apparent differences between wild-type and PG14 neurons in VGCC activation and inactivation kinetics ([Figure 3](#fig3){ref-type="fig"}D), and in the voltage dependence of activation ([Figure 3](#fig3){ref-type="fig"}F), suggesting a reduction in the number of functional channels rather than changes to their biophysical properties.

Evoked excitatory postsynaptic currents (EPSCs) recorded in cultured PG14 CGN by dual whole-cell patch clamp were significantly smaller than in wild-type cells, supporting the view that reduced calcium influx in the mutant neurons impaired glutamate release ([Figures 3](#fig3){ref-type="fig"}G and 3H). The decrease in EPSC amplitude in PG14 neurons was not due to reduced postsynaptic sensitivity to glutamate, as suggested by the increased amplitude (wild-type = 12.07 ± 0.89 pA; PG14 = 16.51 ± 0.88 pA; mean ± SEM, n = 14 for wild-type and n = 13 for PG14; p \< 0.01 by Mann-Whitney U test), and not frequency of miniature events (wild-type = 0.34 ± 0.05 Hz; PG14 = 0.28 ± 0.03 Hz, mean ± SEM; not significant by Mann-Whitney U test). The decrease in EPSC amplitude was rather due to reduced presynaptic calcium currents, as revealed by the increase in facilitation in a protocol of short-term plasticity ([Figure 3](#fig3){ref-type="fig"}I), which is sensitive to the amount of calcium entry ([@bib67]). These results, which are in line with previous reports for mutations of calcium channels affecting excitatory synaptic transmission ([@bib39; @bib40; @bib51]), indicated abnormal VGCC function and impaired glutamatergic neurotransmission in CGN of Tg(PG14) mice.

Defective Calcium Influx in CGNs Is Associated with PG14 PrP Accumulation in Transport Organelles {#sec2.3}
-------------------------------------------------------------------------------------------------

We used two complementary approaches to demonstrate that the VGCC defect was due to mutant PrP expression. First, we tested whether silencing PG14 PrP expression by lentivector-mediated RNAi restored the depolarization-induced calcium rise in mutant CGNs. CGNs from Tg(PG14) mice were transduced with a control lentivirus carrying enhanced green fluorescent protein (EGFP) cDNA (LV-E), or two different lentiviruses encoding EGFP and anti-PrP shRNAs (LV-MW1 and LV-MW2) that efficiently knock down PrP expression ([Figure S4](#app2){ref-type="sec"}) ([@bib65]), and the intracellular calcium rise in response to depolarization was measured in transduced neurons identified by EGFP fluorescence. LV-MW1 and LV-MW2 significantly enhanced the calcium rise in PG14 PrP-expressing but not control cells ([Figure 4](#fig4){ref-type="fig"}A), indicating that knockdown of mutant PrP rescued the cells from the calcium influx defect.

Second, we investigated whether PG14 PrP induced an abnormal calcium response in wild-type neurons. CGNs from C57BL/6J mice were transfected with a bigenic plasmid that drives efficient PrP and EGFP expression in CGNs ([@bib22]), and the depolarization-induced calcium rise was measured in EGFP-positive cells. PG14 PrP-transfected cells had a significantly smaller rise in calcium than untransfected or wild-type PrP-transfected neurons ([Figure 4](#fig4){ref-type="fig"}B), indicating that acute PG14 PrP expression was sufficient to impair VGCC function.

The biosynthetic maturation of misfolded PG14 PrP molecules in the ER is delayed, and they accumulate in the neuronal secretory pathway ([@bib21; @bib25]). To assess whether intracellular PG14 PrP retention plays a role in the VGCC defect, we analyzed the depolarization-induced calcium rise in CGNs transfected with a version of PG14 PrP with a deletion of amino acids 114--121 in the hydrophobic core (PG14/ΔHC). This molecule is less prone to misfolding and delivered to the cell surface more efficiently than its full-length counterpart ([@bib4]). CGNs from C57BL/6 mice were transfected with PG14/ΔHC PrP, or with a version of PrP carrying the hydrophobic core deletion but not the PG14 mutation (ΔHC). The calcium responses of PG14/ΔHC PrP-expressing cells were comparable to those of the wild-type and ΔHC controls ([Figure 4](#fig4){ref-type="fig"}B), suggesting that misfolding and intracellular retention of mutant PrP were necessary to induce the defect in calcium influx.

PG14 PrP Impairs VGCC α~2~δ-1 Subunit Trafficking to the Plasma Membrane {#sec2.4}
------------------------------------------------------------------------

Reduced intracellular calcium influx and current amplitude in PG14 CGNs might be due to changes in VGCC expression, biophysical properties, or membrane targeting. VGCCs are heteromeric proteins consisting of the pore-forming Ca~V~α~1~ subunit, which governs the biophysical and pharmacological properties of the channel, and the auxiliary α~2~δ and Ca~V~β subunits, which regulate the cellular trafficking and activity of Ca~V~α~1~ ([@bib19]). Glutamate release from CGNs is mainly governed by P/Q-type channels made of the Ca~V~α~1A~, α~2~δ-1, and Ca~V~β~4~ subunit isoforms ([@bib47]). To test whether expression of these channels was altered in Tg(PG14) mice, we measured Ca~V~α~1A~ and α~2~δ-1 levels in cerebellar postnuclear supernatants and cultured CGNs. There were no differences in these proteins between Tg(PG14) and Tg(WT) mice (data not shown; [Figure S7](#app2){ref-type="sec"}B), indicating that the calcium defect in the mutant mice was not due to altered VGCC expression.

Because our data pointed to a role of intracellular PG14 PrP retention, we hypothesized that mutant PrP interacted with VGCCs in transport organelles, interfering with their trafficking toward the plasma membrane. Of the different channel subunits, α~2~δ-1 was the best candidate for an interaction with PrP because PrP is a glycosylphosphatidylinositol (GPI)-anchored sialoglycoprotein ([@bib59]) exposed on the outer leaflet of the plasma membrane in cholesterol-rich microdomains (also known as lipid rafts), and there is evidence that α~2~δ-1 is also GPI anchored ([@bib18]). To test whether PrP and α~2~δ-1 interacted physically, we immunoprecipitated PrP from cerebellar extracts of Tg(WT) and Tg(PG14) mice, and immunoblotted the precipitated fractions with an antibody raised against the α~2~ polypeptide of α~2~δ-1. As shown in [Figure 5](#fig5){ref-type="fig"}A, an immunoreactive band of ∼145 kDa was detected in immunoprecipitates of Tg(WT) and Tg(PG14) but not in *Prnp*^0/0^ mice, or when the immunoprecipitation was done in the absence of the anti-PrP antibody. After deglycosylation with PNGaseF, this band shifted to an apparent molecular weight of 107 kDa, as expected for the α~2~ polypeptide ([Figure S5](#app2){ref-type="sec"}A) ([@bib17]).

The interaction was confirmed in the reverse experiment in which α~2~δ-1 was immunoprecipitated from cerebellar extracts and PrP detected by immunoblot ([Figure 5](#fig5){ref-type="fig"}B), and was also seen in primary cultured CGNs ([Figure S5](#app2){ref-type="sec"}B) and transiently transfected HeLa cells ([Figure S5](#app2){ref-type="sec"}C). HC-deleted PrP molecules coimmunoprecipitated with α~2~δ-1 ([Figure S5](#app2){ref-type="sec"}C), indicating that PrP region 114--121 was not essential for the interaction.

Next, we tested whether the distribution of α~2~δ-1 was altered in cells expressing PG14 PrP. HeLa cells were cotransfected with plasmids encoding the Ca~V~α~1A~, Ca~V~β~4~, and α~2~δ-1 subunits, and either wild-type or PG14 PrP-EGFP fusion proteins, and analyzed by confocal microscopy after immunofluorescent staining of α~2~δ-1. Consistent with previous localization of nonfluorescent and EGFP-fused PrPs ([@bib4; @bib25; @bib34]), the majority of wild-type PrP localized on the cell surface ([Figures 6](#fig6){ref-type="fig"}A and 6J), whereas PG14 PrP was mostly found in intracellular compartments ([Figures 6](#fig6){ref-type="fig"}D and 6J). In cells expressing wild-type PrP, α~2~δ-1 was efficiently expressed on the plasma membrane where it colocalized with PrP ([Figures 6](#fig6){ref-type="fig"}B, 6C, and 6K). In contrast, α~2~δ-1 was weakly expressed on the surface of PG14 PrP-expressing cells, and was mostly found in perinuclear patches where it colocalized with PrP ([Figures 6](#fig6){ref-type="fig"}E, 6F, and 6K), and with ER and Golgi markers (data not shown). This was seen in cells with high or low expression levels, ruling out that the abnormal localization of α~2~δ-1 was due to overexpression. The Ca~V~α~1A~ pore-forming subunit also accumulated intracellularly in PG14 PrP-expressing cells ([Figures S6](#app2){ref-type="sec"}A--S6H), whereas there was no effect on the localization of 5′ nucleotidase (5′NT), a raft-resident GPI-anchored protein that does not belong to the VGCC complex ([@bib18]) ([Figures S6](#app2){ref-type="sec"}I--S6P). In cells expressing PG14/ΔHC PrP, α~2~δ-1 was more efficiently delivered to the cell surface, indicating that intracellular retention of mutant PrP played a role in the trafficking defect ([Figures 6](#fig6){ref-type="fig"}H, 6I, and 6K).

To demonstrate that intracellular PrP retention was directly responsible, we analyzed the distribution of α~2~δ-1 in cells expressing PrP molecules artificially targeted to the ER or Golgi. HeLa cells were cotransfected with the Ca~V~α~1A~, Ca~V~β~4~, and α~2~δ-1 subunits, and with a modified version of wild-type PrP in which the GPI signal had been replaced with the ER retention KDEL motif (PrP-ER) or with the transmembrane domain from the rubella virus envelope glycoprotein E2, which contains a Golgi-targeting signal (PrP-Golgi). Double-immunofluorescent staining of PrP-ER with protein disulfide isomerase, and PrP-Golgi with giantin, confirmed the predicted intracellular localization of these constructs ([Figure 7](#fig7){ref-type="fig"}A). In cells expressing PrP-ER or PrP-Golgi, α~2~δ-1 resided in intracellular compartments, colocalizing with PrP ([Figure 7](#fig7){ref-type="fig"}B). Thus, blocking PrP in the ER or Golgi by artificial retention signals resulted in intracellular retention of α~2~δ-1, as with the PG14 mutation.

To investigate whether PG14 PrP expression impaired the cell surface delivery of α~2~δ-1 in neuronal cells too, we immunostained endogenous α~2~δ-1 in nonpermeabilized primary CGNs from wild-type and PG14 mice. The immunofluorescent signal was markedly lower in PG14 CGNs than in the wild-type control ([Figure S7](#app2){ref-type="sec"}A); α~2~δ-1 levels were similar in wild-type and PG14 neurons ([Figure S7](#app2){ref-type="sec"}B), ruling out that the lower α~2~δ-1 level on the surface of PG14 CGNs was due to reduced α~2~δ-1 expression. To test whether the synaptic localization of α~2~δ-1 and Ca~V~α~1A~ was altered in the cerebellum of Tg(PG14) mice, we assessed their levels in purified synaptic membranes by western blot. α~2~δ-1 and Ca~V~α~1A~ levels were significantly lower in the cerebellar synaptosomal fractions of the mutant mice ([Figures S7](#app2){ref-type="sec"}C and S7D). In addition, immunofluorescent staining of the cerebellar molecular layer showed reduced colocalization of α~2~δ-1 with VGLUT1 ([Figure S7](#app2){ref-type="sec"}E), and of Ca~V~α~1A~ with the presynaptic marker VAMP2 ([Figure S7](#app2){ref-type="sec"}F) consistent with impaired VGCC transport to synaptic sites.

Another Pathogenic PrP Mutant Alters α~2~δ-1 Trafficking and Impairs Depolarization-Induced Calcium Influx and Glutamate Release in Primary Neurons and Tg Mice {#sec2.5}
---------------------------------------------------------------------------------------------------------------------------------------------------------------

Next, we asked whether another pathogenic PrP mutant affected VGCC trafficking and function. Like PG14 PrP, mouse PrP carrying the D177N/V128 mutation misfolds and accumulates in the ER of CGNs, and in Tg mice it induces a CJD-like syndrome with motor, cognitive, and electroencephalographic abnormalities ([@bib20]). As was the case for the PG14 mutation, expression of D177N PrP altered α~2~δ-1 localization in HeLa cells ([Figures 8](#fig8){ref-type="fig"}A--8C, 8G, and 8H). This was not seen in cells expressing D177N/ΔHC PrP, which is more efficiently delivered to the cell surface ([@bib4]) ([Figures 8](#fig8){ref-type="fig"}D--8H), confirming that intracellular retention of mutant PrP plays a role in the trafficking defect of α~2~δ-1. CGNs from Tg(CJD) mice expressing D177N/V128 PrP showed a lower depolarization-induced calcium influx ([Figure 8](#fig8){ref-type="fig"}I). Similar to that in Tg(PG14) mice, \[^3^H\]D-aspartate release was reduced in cerebellar synaptosomes of Tg(CJD) mice with motor behavioral abnormalities ([Figures 8](#fig8){ref-type="fig"}J and 8K).

Discussion {#sec3}
==========

The cellular pathways activated by mutant PrP in genetic prion diseases, ultimately leading to neuronal dysfunction and degeneration, are not known. Several mutant PrPs misfold soon after synthesis in the ER and reside longer in transport organelles, suggesting that misfolding and intracellular retention may play a pathogenic role. In the present study we found that early motor behavioral abnormalities in two different Tg mouse models correlate with defective glutamatergic neurotransmission in CGNs. This precedes neurodegeneration and is due to inefficient VGCC-mediated calcium influx in presynaptic terminals. PrP interacts with the VGCC α~2~δ-1 subunit, which regulates the forward trafficking of the channel. Due to mutant PrP retention in transport organelles, α~2~δ-1 accumulates intracellularly, resulting in inefficient targeting of the VGCC complex to synaptic sites. These results provide a cell biological explanation for predegenerative cerebellar dysfunction in genetic prion diseases, and suggest a possible physiological role of PrP in VGCC trafficking and activity.

Impaired Cerebellar Glutamatergic Transmission and Early Motor Disturbances {#sec3.1}
---------------------------------------------------------------------------

Analysis of motor performance on the Rotarod indicates that motor abnormalities in Tg(PG14) mice emerge at ∼45 days of age, long before kyphosis, foot clasp reflex, and the other neurological signs typical of this model ([@bib8; @bib9]). At this stage we found no synaptic or granule cell loss in the cerebellar cortex but a significant decrease of glutamate release from presynaptic terminals, suggesting that mutant PrP leads to perturbation of synaptic transmission independently of neuronal death. Consistent with this, glutamate release was impaired in CGNs isolated from Tg(PG14) mice, which remain healthy in primary culture, and in cerebellar synaptosomes of Tg(CJD) mice, which develop motor disease in the absence of granule cell loss ([@bib20]). Thus, the onset of cerebellar dysfunction and neuron demise are dissociated in mutant PrP mice, as in mouse models of spinocerebellar ataxia type-1 ([@bib23]).

In the cerebellar cortex, parallel fibers (PFs) from granule neurons transmit excitatory glutamatergic inputs to dendrites of Purkinje cells (PCs), which serve as the output system for motor control ([@bib29]). Tg mice in which glutamate exocytosis from PFs is selectively suppressed by conditional expression of tetanus neurotoxin in CGNs develop motor dysfunction that can be rescued by switching off the neurotoxin expression ([@bib66]), indicating a vital role of CGN glutamatergic transmission in sensorimotor function. Because mutant PrP impairs glutamate release in CGNs, as documented by the reduced depolarization-evoked exocytosis and changes in short-term plasticity, the motor deficit in mutant mice is most likely the consequence of inefficient excitatory inputs at the PF-PC synapse.

A number of observations support the idea that synaptic dysfunction induced by abnormal PrP is an important determinant of early behavioral abnormalities in prion diseases. In prion-infected mice defects in presynaptic hippocampal function precede neurodegeneration, and parallel the deficits in hippocampus-dependent spontaneous ethological behaviors, such as recognition memory, burrowing, and nesting ([@bib12; @bib15; @bib43]).

Intracellular Retention of Mutant PrP and VGCC Dysfunction {#sec3.2}
----------------------------------------------------------

Our results indicate that defective glutamate release in the cerebellum of Tg(PG14) mice is due to inefficient VGCC function in CGNs, and that mutant PrP is directly responsible. Lentivirus-mediated knockdown of PG14 PrP restored the depolarization-evoked calcium rise, and transfection of a plasmid encoding PG14 PrP impaired the calcium response in wild-type neurons. The latter observation indicates that PG14 PrP alters calcium dynamics with a dominant effect over wild-type PrP, consistent with a gain-of-toxicity mechanism. However, a loss of a putative PrP function in governing VGCC activity (see below) may also be involved.

Previous analyses suggested that accumulation of mutant PrP in the secretory pathway might be critical in neuronal dysfunction, possibly due to interference with transport and delivery of essential cargo molecules to synapses ([@bib20; @bib44; @bib46]). Here, we found that intracellular retention of mutant PrP was required for perturbing neuronal calcium dynamics, and identified the α~2~δ-1 subunit of VGCCs as a target molecule. We documented a physical interaction between PrP and α~2~δ-1 by coimmunoprecipitation, and the two proteins colocalized in transfected cells, consistent with analysis of the native PrP interactome, which identified α~2~δ subunits as candidate PrP interactors ([@bib54]).

The α~2~δ subunits play a vital role in intracellular trafficking of the pore-forming Ca~V~α~1~ subunits of the Ca~V~1 and Ca~V~2 classes, and boost calcium current amplitude by increasing the number of channels on the cell surface ([@bib6]). α~2~δ interacts with Ca~V~α~1~ during biosynthetic maturation, and promotes the transport of the heteromeric channel complex to correct presynaptic sites ([@bib2; @bib6; @bib30; @bib55]). We found that α~2~δ-1 and Ca~V~α~1A~ were weakly expressed on the cell surface and localized mainly in the ER and Golgi in mutant PrP-expressing cells, suggesting impaired secretory transport. We also found smaller amounts of α~2~δ-1 and Ca~V~α~1A~ in cerebellar synaptosomal fractions of Tg(PG14) mice, and reduced colocalization with synaptic markers, consistent with inefficient targeting of the channel complex to axonal terminals of granule neurons. Thus, the smaller depolarization-evoked calcium rise in cerebellar synaptosomes and in primary CGNs can be explained by the fact that there are fewer functional channels on the plasma membrane.

We previously found that PG14 and D177N PrP molecules with a deletion in the hydrophobic core between residues 114--121 had less tendency to misfold and were more efficiently delivered to the cell surface than their full-length counterparts, providing a model for assessing the role of intracellular retention in neurotoxicity ([@bib4]). By comparing the effect of HC-deleted and full-length molecules on α~2~δ-1 trafficking and calcium dynamics, we provided evidence that VGCC dysfunction depends on intracellular retention of mutant PrP. This, and the fact that PrP interacts physically with the α~2~δ-1 subunit, suggests a mechanism whereby interaction between mutant PrP and α~2~δ-1 results in the latter being sequestered in secretory organelles, impairing correct assembly and delivery of the channel complex to synaptic sites.

Although this can readily explain the low levels of VGCCs at presynaptic terminals, an indirect mechanism might also be involved. PrP may participate in cell signaling governing membrane protein transport ([@bib42]) that could be altered by pathogenic mutations. We did in fact find that cells expressing D177N PrP had an impairment in Rab11-dependent trafficking ([@bib44]), which could potentially affect the endocytic recycling of α~2~δ-1 ([@bib62]).

Our analysis indicates that glutamatergic neurotransmission in Tg(PG14) mice is preferentially impaired in CGNs, in line with the selective expression of α~2~δ-1 by these cells in the cerebellum ([@bib13]). However, α~2~δ-1 is also expressed by glutamatergic neurons in other brain regions ([@bib13]). Therefore, there might be defects in α~2~δ-1 transport and neurotransmission in other neural systems, which could be responsible for additional neurological signs. For example the deficit in spatial working memory in Tg(CJD) mice ([@bib20]) might depend on abnormal glutamatergic function in the hippocampus.

Three different α~2~δ subunits are expressed in functionally distinct neurons of the brain, with the α~2~δ-2 and α~2~δ-3 isoforms sharing, respectively, 55.6% and 30.3% sequence identity with α~2~δ-1 ([@bib36]). It will be interesting to see if PrP interacts with α~2~δ-2 and α~2~δ-3, and if their cellular trafficking is affected by mutant PrP, as with α~2~δ-1. It will also be important to see whether VGCC dynamics are perturbed in prion diseases acquired by infection. N-type VGCC function is impaired in prion-infected hypothalamic GT1-1 cells ([@bib56]), but it is not clear whether this is due to deficient channel insertion in the plasma membrane.

At an advanced stage of disease, Tg(PG14) mice show synaptic degeneration in the cerebellar molecular layer and apoptosis of granule neurons, raising the possibility that functional impairment of α~2~δ subunits resulting from sequestration by mutant PrP may eventually lead to synaptic disruption and neuron demise. Consistent with this, targeted deletion or spontaneous mutation of the mouse *Cacna2d2* gene encoding α~2~δ-2, which is primarily present in Purkinje neurons, results in cerebellar ataxia with PC depletion and apoptosis of granule neurons ([@bib1; @bib33]). It is striking that mutations in other VGCC subunits also often result in cerebellar degeneration in mice ([@bib49]), perhaps because cerebellar neurons are more sensitive to changes in calcium levels, or less able to activate compensatory responses than neurons of other brain regions. In this regard the fact that glutamate release was not consistently impaired in the cerebral cortex of Tg(PG14) mice despite high α~2~δ-1 expression ([@bib13]) may be due to upregulation of cellular pathways that positively affect VGCC trafficking and activity ([@bib58]).

Possible Physiological Significance of the PrP-α~2~δ-1 Interaction {#sec3.3}
------------------------------------------------------------------

Our findings that wild-type PrP and α~2~δ-1 are coimmunoprecipitated from mouse brain extracts and colocalize in transfected cells suggest a role of PrP in VGCC function. In line with this, cerebellar granules and hippocampal CA1 neurons lacking PrP showed alterations in L-type VGCC-dependent calcium dynamics ([@bib28; @bib31]). In addition, treatment of synaptosomes with recombinant PrP resulted in cytosolic calcium elevation that was inhibited by gadolinium---a nonselective VGCC blocker---and an anti-PrP monoclonal antibody impaired the calcium response to depolarization ([@bib64]). Finally, exposure of neurons to full-length PrP or N-terminal fragments affected L-type VGCC-mediated calcium entry ([@bib26; @bib38]). Although we found no significant deficits in depolarization-evoked calcium influx in cerebellar synaptosomes from PrP-deficient mice, there was a modest but significant decrease in primary CGNs lacking PrP (data not shown), consistent with an effect on somatic channels (predominantly L-type) ([@bib31]).

PrP might regulate VGCC activity through several mechanisms. Interaction with α~2~δ-1 in the ER might titrate its association with Ca~V~α~1A~ and fine-tune the anterograde transport of the channel complex. Alternatively, PrP may influence the channel activity by associating with α~2~δ-1 on the plasma membrane, or acting as a scaffold protein to target the channel complex to specific membrane microdomains ([@bib41]). Like other GPI-anchored proteins, α~2~δ-1 is preferentially located in detergent-resistant lipid rafts ([@bib17; @bib18]). This lipid raft localization appears to be independent of the GPI-anchoring motif ([@bib53]), suggesting that it may rely on interaction with other raft-resident proteins, such as PrP. Finally, the PrP-α~2~δ-1 interaction may have a physiological significance unrelated to the channel activity. Recent findings, in fact, show that α~2~δ-1 is involved in synaptogenesis ([@bib24]), a function in which PrP has also been involved ([@bib35; @bib48; @bib57]).

Clearly, further studies are required to establish the physiological significance of the PrP-α~2~δ-1 interaction. It will be critical to identify the protein domain(s) involved in the interaction, and any other interacting partners. In light of the dysfunctional consequences of the mutant PrP association with α~2~δ-1, disrupting their binding might represent a means for therapeutic intervention.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

The production of Tg mice expressing wild-type, PG14, and D177N/V128 mouse PrPs with an epitope for the monoclonal antibody 3F4 has already been reported by [@bib8] and [@bib20]. In this study we used Tg mice of the Tg(WT-E1^+/+^) line, which expresses about four times the endogenous PrP level, referred to throughout the text as Tg(WT); we also used Tg(PG14-A3^+/−^) and Tg(D177N/V128-A21^+/−^) mice expressing Tg PrP at approximately one time, referred to as Tg(PG14) and Tg(CJD), respectively. These mice were originally generated on a C57BL/6J X CBA/J hybrid and were then bred with the Zurich I line of *Prnp*^0/0^ mice ([@bib5]) with a pure C57BL/6J background (European Mouse Mutant Archive, Monterotondo, Rome; EM:01723). C57BL/6J mice were purchased from Charles River Laboratories.

All procedures involving animals were conducted according to European Union (EEC Council Directive 86/609, OJ L 358,1; December 12, 1987) and Italian (D.L. n.116, G.U. suppl. 40, February 18, 1992) laws and policies, and were in accordance with the United States Department of Agriculture Animal Welfare Act and the National Institutes of Health Policy on Humane Care and Use of Laboratory Animals. They were reviewed and approved by the Mario Negri Institute Animal Care and Use Committee that includes ad hoc members for ethical issues (18/01-D, 18/01-C). Animal facilities meet international standards and are regularly checked by a certified veterinarian who is responsible for health monitoring, animal welfare supervision, experimental protocols, and review of procedures.

MRI {#sec4.2}
---

Animals were anesthetized with 1% isoflurane in a 30%:70% O~2~:N~2~O gas mixture and imaged in a horizontal bore 7-Tesla USR preclinical MRI system (BioSpec 70/30; Bruker BioSpin, Germany) with a shielded gradient insert (BGA 12, 400 mT/m; rise time, 110 us). A 7 mm birdcage resonator for RF transmission and a 10 mm diameter single-loop receiver coil were used to receive the signal. T2-weighted anatomical images of the mouse brain were acquired with the following parameters: TR 2500 ms, TE 50 ms, RARE factor 16, FOV 3 × 1.5 × 1.5 cm, Matrix 256 × 102 × 102, voxel 0.147 × 0.117 × 0.147. The scan time was approximately 25 min. The cerebellar volume was quantified using the ImageJ software (<http://rsbweb.nih.gov/ij/>).

Accelerated Rotarod Test {#sec4.3}
------------------------

We used an accelerating Rotarod 7650 model (Ugo Basile). Juvenile mice were tested starting from 19 days of age (P19) for 7 consecutive days. On the first day a training session was done during which each mouse was placed on the Rotarod at a constant speed (4 rpm) for a maximum of 60 s. Then they were assessed in three consecutive test sessions with a 10 min intertrial resting period. They were positioned on the rotating bar and allowed to become acquainted with the environment for 30 s. The rod motor was started initially at 4 rpm and accelerated to 40 rpm at a constant rate of 0.12 rpm/s for a maximum of 300 s. Adult mice were trained three times the week before official testing. The performance was scored as latency to fall, in seconds. Animals were given three trials, and the average was used for statistical analysis.

Synaptosome Preparation {#sec4.4}
-----------------------

Synaptosomes were isolated from the cerebral cortex and the cerebellum using a discontinuous Percoll gradient as described by [@bib60].

Cells {#sec4.5}
-----

Primary CGNs were prepared from 6-day-old mice as described by [@bib4]. HeLa cells were grown in a 1:1 mixture of Dulbecco\'s modified Eagle\'s medium (DMEM) and minimal essential medium α (MEM), supplemented with GlutaMAX (Invitrogen), 10% FBS, nonessential amino acids (Sigma-Aldrich), 100 U/ml penicillin, and 100 μg/ml streptomycin (GIBCO), and maintained at 37°C in 5% CO~2~/95% air. Plasmid transfections and transduction with lentiviral vectors were done as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Biochemical Analyses {#sec4.6}
--------------------

Detergent insolubility and immunoprecipitation with antibody 15B3 were assayed as described by [@bib3] and [@bib8]. Coimmunoprecipitation was done as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Immunofluorescence Staining {#sec4.7}
---------------------------

Immunofluorescence staining of cells and brain sections was performed as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Antibodies {#sec4.8}
----------

Antibodies used for western blot, immunoprecipitation, and immunofluorescence are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Neurotransmitter Uptake and Release {#sec4.9}
-----------------------------------

Neurotransmitter uptake and release from synaptosomes and CGNs were done according to published protocols by [@bib60], and are described more fully in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Calcium Measurements {#sec4.10}
--------------------

Calcium levels in synaptosomes were determined spectrofluorimetrically after incubating purified synaptosomes with the calcium-sensitive fluorescent dye fura-2 AM. Synaptosomes washed in Tris/acetate buffer (128 mM NaCl, 5 mM KCl, 1 mM MgSO~4~, 1.5 mM NaHPO~4~, 10 mM glucose, 10 mM Tris/HCl \[pH 7.4\]) were resuspended at a total protein concentration of 1 μg/μl and loaded with fura-2 AM 5 μM at 37°C for 30 min in Tris/acetate buffer plus BSA 1%. After centrifugation at 16,000 × *g* for 5 min, synaptosomes were resuspended at a final protein concentration of 0.25 μg/μl in Tris/acetate buffer plus 1 mM CaCl~2~ and aliquoted in 96-well plates (50 μg protein/well). Fluorescence was measured at 37°C for 200 cycles, each cycle alternating excitation at 340 and 380 nm and monitoring emission at 510 nm. Depolarization was induced by injecting 50 mM KCl at cycle 50. The fluorescence ratio F340:380 was measured for each cycle, and data were reported as ΔF340/380, the difference between F340/380 before and after the stimulus, which is proportional to the KCl-induced Ca^2+^ influx. Single-cell calcium imaging was done as described by [@bib63] using an Olympus IX81 inverted microscope equipped with a calcium imaging unit (Cell^R^; Olympus).

Electrophysiology {#sec4.11}
-----------------

Whole-cell VGCC currents were recorded from CGNs as described by [@bib14]. For evoked and miniature EPSC recordings, CGNs were bathed in an external solution containing 125 mM NaCl, 5 mM KCl, 1.2 mM MgSO~4~, 2 mM CaCl~2~, 1.2 mM KHPO~4~, 25 mM HEPES, 10 mM Glu (pH 7.4). For miniature recordings 1 μM tetrodotoxin was added. Patch pipettes were filled with internal solutions (130 mM KGluc, 1 mM EGTA, 10 mM KCl, 2 mM MgCl~2~, 10 mM HEPES, 4 mM Mg-ATP, and 0.3 mM Tris-GTP). EPSCs for paired pulse recordings were evoked from monosynaptically coupled neurons by pairs of 2 ms depolarizing pulses from −70 to 30mV (50 ms interpulse interval \[20 Hz\]) every 5 s. During miniature EPSCs and paired-pulse recordings, cells were held at −70mV (unless otherwise stated). Series resistance ranged from 10 to 20 MΩ and was monitored for consistency during recordings. Cells in culture with leak currents \>100 pA were excluded from the analysis. Signals were amplified, sampled at 10 kHz, filtered to 2 or 5 KHz, and analyzed using pClamp 10 data acquisition and analysis program.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7and Supplemental Experimental Procedures

We thank Giovanna R. Mallucci for the lentiviruses expressing shRNAs targeting PrP, and David Westaway for the pBud-EGFP plasmid. We also thank David A. Harris for the P45-66 antibody and the PrP-ER and PrP-Golgi constructs, Richard Kasksak for the 3F4 antibody, Jan P. Langeveld for the 12B2, 94B4, 98A3 and R505 antibodies, and Alex Raeber from Prionics (Zurich, Switzerland) for the 15B3 antibody. We are grateful to Simona Airaghi, Davide Pozzi and Egidio D\'Angelo for participating in the initial phase of this project; to Pietro Veglianese for advice on time-lapse and confocal microscopy; to Elisabetta Menna and Stefano Fumagalli for advice on immunofluorescence quantification; to Luisa Diomede for advice on calcium measurement in synaptosomes; to Alan Zanardi for help with primary CGN culture; and to Michele Sallese for comments on the manuscript. This work was supported by grants from Telethon Italy (TCR08005), "Fondazione Cariplo" (2008-2338 and 2010-0828), the E.C. Network of Excellence NeuroPrion (FOOD-CT-2004-506579), the European Union Seventh Framework Programme under grant agreement HEALTH-F2-2009-241498 ("EUROSPIN" project), and by the Italian Ministry of Health (Malattie Rare RF-INN-2008-1215065). A.S. was supported by an anonymous fellowship grant. R.C. is an Associate Telethon Scientist (Dulbecco Telethon Institute, Fondazione Telethon). This work is dedicated to the memory of Renato Dulbecco (February 22, 1914, Catanzaro, Italy --- February 19, 2012, La Jolla, CA, USA).

Supplemental Information includes seven figures and Supplemental Experimental Procedures and can be found with this article online at [doi:10.1016/j.neuron.2012.02.027](10.1016/j.neuron.2012.02.027).

![Tg(PG14) Mice Develop Deficits in Motor and Balance Coordination before Cerebellar Degeneration\
(A) Groups of 6--15 Tg(WT), 7--12 Tg(PG14) mice, and 6--17 non-Tg littermates were tested on a Rotarod at the ages indicated. Each mouse was tested three times. Bars indicate the mean ± SEM latency to fall (s); ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus Tg(WT) by one-way analysis of variance (ANOVA), Bonferroni\'s post hoc test.\
(B) Brain anatomy of non-Tg, Tg(WT), and Tg(PG14) mice at the ages indicated. Representative T2-weighted images (TE/TR = 50/2,500 ms).\
(C) Cerebellar volumes (mm^3^) of non-Tg, Tg(WT), and Tg(PG14) mice at the ages indicated. Mean ± SD. The number of animals is given in parentheses. ^∗∗∗∗^p \< 0.0001 versus non-Tg and Tg(WT) by two-way ANOVA, Bonferroni\'s post hoc test.](gr1){#fig1}

![Cerebellar Tg(PG14) Synaptosomes Show Impaired Depolarization-Evoked Glutamate Release and Calcium Influx\
(A) Cerebellar synaptosomes from 230- to 250-day-old mice were preloaded with \[^3^H\]D-aspartate and stratified on filters in a 20 chamber superfusion apparatus. After equilibration, synaptosomes were exposed to 15 mM KCl for 1.5 min. The K^+^-induced \[^3^H\]D-aspartate overflow was measured in the collected fractions. Each error bar indicates the mean ± SEM of 5--20 replicate chambers from 2 to 4 independent experiments. Data are expressed as percentages of the values of Tg(WT) mice. ^∗^p \< 0.05 versus corresponding value in Tg(WT) by Student\'s t test.\
(B) K^+^-induced release was determined in cerebellar synaptosomes from Tg(WT) and Tg(PG14) mice of the ages indicated. Each bar indicates the mean ± SEM of 5--14 replicates from 1 to 3 independent experiments. ^∗^p \< 0.05 and ^∗∗^p \< 0.01 by Student\'s t test.\
(C) Depolarization-induced release was determined in synaptosomes from the cerebral cortex of the same Tg(WT) and Tg(PG14) mice used in (B). Each bar indicates the mean ± SEM. ^∗^p \< 0.05 versus corresponding value of Tg(WT) by Student\'s t test.\
(D) Cerebellar synaptosomes were preloaded with fura-2 AM and depolarized with 50 mM KCl. The K^+^-induced \[Ca^2+^\]~i~ rise is expressed as percent ΔF (difference of the fluorescence ratio F340/380 before and after the stimulus) of K^+^-induced calcium responses in synaptosomes of Tg(WT) mice. Each bar indicates the mean ± SEM of 9--21 replicates from 2 to 4 independent synaptosomal preparations pooling 13 Tg(WT), 12 Tg(PG14), 4 *Prnp*^0/0^, and 4 *Prnp*^+/+^ mice of 230--250 days. ^∗^p \< 0.05 and ^∗∗∗^p \< 0.001 versus corresponding value for Tg(WT) by Student\'s t test.](gr2){#fig2}

![Depolarization-Evoked \[^3^H\]D-Aspartate Release, Calcium Currents, and Glutamatergic Neurotransmission Are Impaired in Primary CGNs from Tg(PG14) Mice\
(A) K^+^-induced \[^3^H\]D-aspartate release from primary cultures of CGNs from Tg(WT) and Tg(PG14) mice. Each value represents the mean ± SEM of 13--20 replicates from 3 independent experiments. ^∗^p \< 0.05 by Student\'s t test.\
(B) CGNs preloaded with 10 μM fura-2 AM were depolarized with 30 mM KCl. K^+^-induced \[Ca^2+^\]~i~ rise was measured in single cells and expressed as ΔF. Values are the mean ± SEM of 129 cells from Tg(WT) and 286 cells from Tg(PG14) mice. ^∗∗∗^p \< 0.001 by Student\'s t test.\
(C) Representative pseudocolor images of fura-2 AM-loaded CGNs stimulated with 30 mM KCl. The images were taken before the stimulus (a and b), at an intermediate (c and d), and at the peak response (e and f). The color scale is shown on the left. Scale bar, 50 μm.\
(D) Representative whole-cell VGCC inward Ba^2+^ currents in response to 10 mV increment step depolarizations from −80 to 60mV recorded in CGNs from Tg(WT) and Tg(PG14).\
(E) Mean IV relationship of peak I~Ba~ recorded in CGNs from Tg(WT) and Tg(PG14), in response to 250 ms voltage pulses in 10mV increments from −80 to 60mV. I~Ba~ current densities (pA/pF) are shown as mean ± SEM; n = 17 for Tg(WT) and n = 10 for Tg(PG14).\
(F) Voltage-dependent activation curves of VGCC currents generated in Tg(WT) (n = 8) and Tg(PG14) (n = 6) CGNs by measuring tail currents stimulated by a repolarization to −40mV, normalizing to the largest tail current in the series and then plotting against the prepulse voltage.\
(G) Cultured CGNs from wild-type (C57BL/6J) and Tg(PG14) mice were voltage clamped at a holding potential of −70mV, and EPSCs were evoked by pairs of 1 ms depolarizing pulse to 30mV at 50 ms interpulse interval. Representative sample traces are shown.\
(H) Amplitude of the first evoked EPSC in wild-type and PG14 neurons.\
(I) The PPR value was calculated as the ratio of the amplitudes of the second to the first EPSC.\
Bars in (H) and (I) indicate the mean ± SEM of 10 wild-type and 11 PG14 cells. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001 by Mann-Whitney U test.](gr3){#fig3}

![Defective Calcium Influx in CGNs Is Due to PG14 PrP Expression and Accumulation in Secretory Organelles\
(A) Primary CGNs from C57BL/6J and Tg(PG14) mice were transduced with 1--5 × 10^6^ TU/ml of lentiviruses encoding anti-PrP shRNA (LV-MW1 or LV-MW2), or with a lentivirus lacking shRNA (LV-E). The depolarization-induced \[Ca^2+^\]~i~ rise was measured in lentivirus-exposed CGNs and expressed as ΔF. Each bar indicates the mean ± SEM of cells transduced by the LV-E (40 C57BL/6J and 20 PG14 cells), LV-MW1 (19 C57BL/6J and 13 PG14 cells), and LV-MW2 (9 C57BL/6J and 27 PG14 cells). ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001 by two-way ANOVA, Bonferroni\'s post hoc test.\
(B) Primary CGNs from C57BL/6J mice were transfected with pBUD-GFP plasmid carrying the wild-type, PG14, PG14/ΔHC, or ΔHC PrP cDNA. The K^+^-induced \[Ca^2+^\]~i~ rise was measured in GFP-positive cells and expressed as ΔF. Each bar is the mean ± SEM of 330 wild-type, 235 PG14, 299 PG14/ΔHC, and 192 ΔHC PrP-expressing cells. ^∗∗∗^p \< 0.001 versus the corresponding value of Tg(WT) by one-way ANOVA, Bonferroni\'s post hoc test.](gr4){#fig4}

![PrP and α~2~δ-1 Are Coimmunoprecipitated from Brain Extracts\
(A) Cerebellar protein extracts (500 μg) from Tg(WT), Tg(PG14), and *Prnp*^0/0^ (KO) mice were incubated with uncoated magnetic beads (lanes 1--3) or magnetic beads coated with anti-PrP monoclonal antibody 94B4 (lanes 4--6). The immunoprecipitated proteins were analyzed by western blot with an anti-α~2~δ-1 antibody (upper panel) or anti-PrP polyclonal antibody P45-66 (lower panels). The input (lanes 7--9) is 25 μg of total protein.\
(B) Cerebellar protein extracts (500 μg) from the same animals as in (A) were incubated with uncoupled magnetic beads (lanes 1--3) or magnetic beads coated with anti-α~2~δ-1 polyclonal antibody (lanes 4--6). The immunoprecipitated proteins were analyzed by western blot with an anti-α~2~δ-1 monoclonal antibody (upper panel) or anti-PrP monoclonal antibody 12B2 (lower panels). The input (lanes 7--9) is 25 μg of total protein.](gr5){#fig5}

![α~2~δ-1 Is Retained in Intracellular Compartments of Cells Expressing PG14 PrP\
(A--I) HeLa cells were cotransfected with plasmids encoding wild-type, PG14, or PG14/ΔHC PrP-EGFP fusion protein, and the VGCC subunits Ca~V~α~1A~, Ca~V~β~4~, and α~2~δ-1 (0.5:3:2:2 ratio). After 48 hr, cells were fixed, permeabilized, stained with anti-α~2~δ-1 monoclonal antibody followed by Alexa 594 (red)-conjugated anti-mouse IgG secondary antibody, and reacted with DAPI (blue) to stain the nuclei. Scale bar, 20 μm. The fluorescent density of PrP-EGFP (J) and α~2~δ-1 (K) on the cell surface was measured and expressed as a percentage of the total. Each bar indicates the mean ± SEM of 28 wild-type, 48 PG14, and 8 PG14/ΔHC transfected cells. ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001 by one-way ANOVA, Dunn\'s post hoc test. n.s., not significant.](gr6){#fig6}

![Targeting PrP to the ER or Golgi Induces Intracellular Accumulation of α~2~δ-1\
HeLa cells were cotransfected with plasmids carrying cDNAs encoding PrP-ER or PrP-Golgi and the VGCC subunits α~1A~, Ca~v~β4, and α~2~δ-1 (0.5:3:2:2 ratio).\
(A) After 48 hr, cells were fixed, permeabilized, and stained with anti-PrP monoclonal antibody 98A3 (green), and polyclonal antibodies against protein disulfide isomerase (PDI) or giantin to stain the ER or Golgi (red).\
(B) Transfected cells were stained with anti-PrP polyclonal antibody R505 (green) and an anti-α~2~δ-1 monoclonal antibody (red). Cells were reacted with DAPI (blue) to stain the nuclei.\
Scale bars, 20 μm.](gr7){#fig7}

![The D177N PrP Mutation Alters α~2~δ-1 Trafficking and Impairs Depolarization-Induced Calcium Influx and Glutamate Release\
(A--F) HeLa cells were cotransfected with plasmids encoding D177N or D177N/ΔHC PrP-EGFP fusion protein, and the VGCC subunits Ca~V~α~1A~, Ca~V~β~4~, and α~2~δ-1 (0.5:3:2:2 ratio). After 48 hr, cells were fixed, permeabilized, stained with anti-α~2~δ-1 monoclonal antibody followed by Alexa 594 (red)-conjugated anti-mouse IgG secondary antibody, and reacted with DAPI (blue) to stain the nuclei. Scale bar, 20 μm. The fluorescent density of PrP-EGFP (G) and α~2~δ-1 (H) on the cell surface was measured and expressed as a percentage of the total. Each bar indicates the mean ± SEM of 11 D177N and 19 D177N/ΔHC transfected cells. ^∗∗∗^p \< 0.001 by Mann-Whitney U test.\
(I) Primary cultures of CGNs from C57BL/6J (wild-type) and Tg(CJD) mice were preloaded with 10 μM fura-2 AM and depolarized with 30 mM KCl. The K^+^-induced \[Ca^2+^\]~i~ rise was measured in single cells and expressed as ΔF. Values are the mean ± SEM of 540 cells from C57BL/6J and 607 cells from Tg(CJD) mice, from 3 independent experiments. ^∗∗∗^p \< 0.001 by Student\'s t test.\
(J) Depolarization-induced \[^3^H\]D-aspartate release was determined in cerebellar synaptosomes from 489- to 520-day-old Tg(WT) and Tg(CJD) mice. Each bar indicates the mean ± SEM of 2 independent analyses (18 superfusion chambers per experimental group) of synaptosomes from 5 Tg(WT) and 5 Tg(CJD) mice. ^∗∗^p \< 0.01 versus the corresponding values of Tg(WT) by Student\'s t test.\
(K) Groups of 9--20 C57BL/6J (wild-type) and 3--12 Tg(CJD) mice were tested on a Rotarod at the ages indicated. Each mouse was tested three times, and the mean latency to fall was calculated. Bars indicate the mean ± SEM latency to fall (s). ^∗^p \< 0.05, ^∗∗∗^p \< 0.001 by Student\'s t test.](gr8){#fig8}
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